New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide March 30, 2024 AutoBot News 0 For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com Source